The C9ORF72 gene helps nerve cells and immune cells manage waste and move materials where they are needed. This gene plays an important role in keeping brain cells healthy, and when it does not work properly, some people develop amyotrophic lateral sclerosis (ALS) or a form of dementia that mainly affects behavior and language. A repeat expansion in the C9ORF72 gene is one of the most common inherited genetic causes of ALS and frontotemporal dementia.
What is a gene?
A gene is a section of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, which are the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
C9Gene function
What if the gene works
The C9 gene helps your immune system make complement component 9, a protein used to form tiny holes in some germs. This supports the body’s defense against certain infections.
Risk
What if the gene does not work
When the C9 gene does not work properly, the final step of the complement immune pathway may be weaker. Milder variants may partly reduce C9 activity, while more disruptive variants can cause C9 deficiency and are linked to meningococcal disease.
Treatment
What does that mean for your treatment
Pathogenic loss of function variants in the C9 gene do not have a C9 replacement treatment, but they do guide management. Care usually focuses on up to date meningococcal vaccination and, in some people, preventive antibiotics or rapid antibiotic treatment at the first sign of fever. These steps reflect the higher risk of invasive meningococcal infection.
Conditions associated with C9
Gene function
What if the gene works
Your blood and tissues constantly meet bacteria and other microbes. The C9 gene helps one of your body’s fast defense systems finish the job against certain germs. It supports a protein that joins other immune proteins to damage the outer surface of invading microbes.
The C9 gene helps complete the complement system, a fast blood based defense pathway. Its protein joins other late complement proteins on a germ’s surface to finish the attack.
C9 proteins line up to form a small pore (opening) in the outer layer of a target microbe. This opening disrupts the membrane and helps the immune system clear the germ.
C9 works with C5b, C6, C7, and C8 to build the membrane attack complex, a hole making immune structure. This teamwork is central to the C9 gene’s function in the immune system.
The C9 protein circulates in blood in an inactive form until it is recruited to a target. This helps keep the response focused and supports day to day protection against microbes.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including traits such as appearance, metabolism, and the way the body reacts to environmental influences. Many do not produce any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Research on how C9 gene variants affect protein function shows that some changes reduce how much C9 protein is made, while others make the protein unstable or less able to join other complement proteins. Milder variants may leave partial activity. More severe variants, including changes that truncate the protein or disrupt splicing, can lead to little or no working C9 and are more often linked to clearer C9 deficiency.
How variants are linked to conditions
Pathogenic variants in the C9 gene cause complement component 9 deficiency, a rare inherited immune condition. People with this diagnosis are more likely to have recurrent meningococcal disease and other serious Neisseria infections, often starting in childhood or early adult life. In practice, C9 gene variants are linked to infection risk rather than a broad range of unrelated conditions.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found commonly throughout the general population. Most do not directly affect health and instead reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental influences are involved. In some instances, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful repeat expansion in the C9 gene, the main risk is largely set by that genetic change, and the chance of developing symptoms rises with age. Family history can also matter. There is not enough evidence to say that specific lifestyle changes lower this risk, so follow-up usually focuses on watching for early symptoms and planning care.
Inheritance of C9 variants
For families asking how C9 gene variants are inherited, the well-established pattern for C9-related complement C9 deficiency is autosomal recessive. This means a person usually inherits one altered copy of the C9 gene from each parent, and parents who carry one altered copy typically do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of a child who is a carrier, and a 25% chance of a child with two working copies.
What does my C9 result mean for my family?
For families, the meaning of a C9 result depends on which health issue the result is tied to. When it relates to C9 deficiency, which can raise the chance of certain serious bacterial infections, close relatives may also carry the same change, and brothers, sisters, or children could want to learn whether they are carriers or affected. This family pattern is usually recessive, so parents are often healthy carriers.
Genetic information
Genetic testing
How you find out about variants
C9 genetic testing shows how genetic testing for C9 variants works in practice: a lab uses a blood or saliva sample to read the DNA in the C9 gene and look for specific variants. The result can show whether a known change is present. It helps clarify variant status, but it does not by itself explain every symptom or predict the future.
When should I consider getting a genetic test?
Genetic testing for the C9 gene may be worth discussing if you or a close relative has had repeated meningococcal infections, such as meningitis or serious bloodstream infections, especially at a young age. It can also help clarify a known family history of complement deficiency, a condition that weakens part of the body's infection defense.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it reveals depends on the condition and the specific type of variant. Over time, how the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put a person’s individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect responses to medications. It explores relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the C9 gene
When should I seek medical advice?
This gene does not yet have a broadly confirmed role in how people respond to medicines, so any concerns about treatment, side effects, or overall health are best discussed with your doctor.
History
The C9ORF72 gene entered modern medical history in 2011, when researchers identified a repeated DNA sequence expansion in this gene as a major cause of inherited amyotrophic lateral sclerosis and frontotemporal dementia. Before that finding, families with these conditions had shown a strong link to chromosome 9, but the exact genetic change had remained elusive for years. From these first observations, research expanded steadily. The discovery was a turning point because it connected two conditions that had often been studied separately and explained many long-standing family patterns. It also reshaped genetic testing for people with a family history of ALS or frontotemporal dementia. Since then, the C9ORF72 gene has become one of the most studied genes in neurogenetics.